Results of the Childhood Cancer and Leukaemia Group's United Kingdom Relapsed Wilms Tumour Trial
Key Points
The aim is to evaluate the survival rates of children with relapsed Wilms tumour after risk stratification and high-dose chemotherapy.
Conducted a trial on children with relapsed Wilms tumour
Implemented risk stratification techniques
Administered high-dose chemotherapy in treatment protocol
Survival rates improved compared to historical data
Indicates effectiveness of risk stratification and high-dose chemotherapy
Abstract
Survival rates following risk stratification including M + ASCT are higher than historical observations for similar high-risk groups that did not include high-dose chemotherapy.